Medicare

Intellia and Regeneron Announce Initial Data from the Cardiomyopathy Arm of Ongoing Phase 1 Study of NTLA-2001, an Investigational CRISPR Therapy for the Treatment of Transthyretin (ATTR) Amyloidosis

Icario Launches Benefits Care Card to Bring New Levels of Flexibility to Medicare Advantage Member Rewards and Incentives

User-friendly Card Gives Members Easy Access to Benefits Including OTC Medication, Nutrition, Hearing, Fitness and VisionMINNEAPOLIS, Sept. 15, 2022 (GLOBE...

BrainsWay Announces Significant Private Insurance Coverage from Cigna Corporation for the Treatment of OCD Utilizing Deep TMS™

Cigna® Issues Favorable Policy for Deep TMS to Address Medication-Resistant Obsessive-Compulsive DisorderBURLINGTON, Mass. and JERUSALEM, Israel, Sept. 14, 2022 (GLOBE...

Press Release: Late-breaking Dupixent® (dupilumab) data at ERS 2022 show consistent efficacy and safety profile for up to two years in children aged 6 to 11 years with moderate-to-severe asthma

MULTIMEDIA UPDATE — Social Threats to Aging Well in America: New Study Reveals Economic Instability, Loneliness, Food Insecurity as Top 3 Barriers to Senior Health

National survey from Alignment Healthcare explores issues preventing seniors from accessing care, provides insights into possible solutions Top 3 Social...

error: Content is protected !!